$40.00
PT-141
Melanocortin & Sexual-Function Research
PT-141, also known as bremelanotide, is a melanocortin receptor agonist developed to investigate pathways involved in sexual desire and arousal.
Unlike traditional treatments that act primarily through vascular mechanisms, PT-141 works through central melanocortin signaling pathways.
Bremelanotide has undergone clinical development and is an FDA-approved prescription medication for a specific indication in premenopausal women. Its approved medical use should not be generalized to other populations or purposes.
Research Focus: Melanocortin signaling • Sexual-function research • Neuroendocrine pathways
Research Status: Prescription medication for a specific FDA-approved indication.
12 in stock
PT-141
Melanocortin & Sexual-Function Research
PT-141, also known as bremelanotide, is a melanocortin receptor agonist developed to investigate pathways involved in sexual desire and arousal.
Unlike traditional treatments that act primarily through vascular mechanisms, PT-141 works through central melanocortin signaling pathways.
Bremelanotide has undergone clinical development and is an FDA-approved prescription medication for a specific indication in premenopausal women. Its approved medical use should not be generalized to other populations or purposes.
Research Focus: Melanocortin signaling • Sexual-function research • Neuroendocrine pathways
Research Status: Prescription medication for a specific FDA-approved indication.
